2010
DOI: 10.1016/j.biocel.2010.08.014
|View full text |Cite
|
Sign up to set email alerts
|

Megakaryoblastic leukemia protein-1 (MKL1): Increasing evidence for an involvement in cancer progression and metastasis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

1
43
0

Year Published

2011
2011
2023
2023

Publication Types

Select...
5
3
1

Relationship

0
9

Authors

Journals

citations
Cited by 54 publications
(44 citation statements)
references
References 29 publications
1
43
0
Order By: Relevance
“…Among our top hits for both statistics are multiple SNPs that fall in the gene MKL1 (megakaryoblastic leukemia 1), which is a myocardin-related transcription factor that is involved in smooth muscle cell differentiation, mammary gland function, and cytoskeletal signaling (Parmacek 2007;Maglott et al 2011) and has been associated with various disease phenotypes (Ma et al 2001;Hinohara et al 2009;Scharenberg et al 2010).…”
Section: Robust Candidates In the Hgdp Datamentioning
confidence: 99%
“…Among our top hits for both statistics are multiple SNPs that fall in the gene MKL1 (megakaryoblastic leukemia 1), which is a myocardin-related transcription factor that is involved in smooth muscle cell differentiation, mammary gland function, and cytoskeletal signaling (Parmacek 2007;Maglott et al 2011) and has been associated with various disease phenotypes (Ma et al 2001;Hinohara et al 2009;Scharenberg et al 2010).…”
Section: Robust Candidates In the Hgdp Datamentioning
confidence: 99%
“…These activities cause a depletion of G-actin, thereby allowing MRTF to activate SRF-dependent transcription. The deregulation of MRTF activity has been implicated in various diseases (48). For instance, it was proposed previously that aberrantly increased MRTF/SRF activity enhances the migration potential of breast cancer (BC) cells (5,27).…”
mentioning
confidence: 99%
“…This notion is supported by recent evidence, showing that ablation of ATE1 expression in platelets in vivo did not lead to an impairment in actin polymerization but rather induced the contractile capacity of these cells during clot retraction (22). Also, MRTF-A activity has been shown to play different roles depending on the cell type, the tissue environment, and the signaling pathways in which it is involved (6). For example, a role for MRTF-A has emerged in tumorigenesis, i.e.…”
Section: Discussionmentioning
confidence: 55%
“…Although few publications acknowledged a link between deregulated MRTF-A activity and carcinogenesis (6), its molecular role and mode of action in regulating cellular motility appear to depend on the cell type. Whereas silencing of MRTF-A expression in breast cancer cells reduced cellular motility in vitro as well as inhibited experimental metastasis in vivo (7,8), partial reduction of MRTF-A in murine fibroblastic or epithelial cells induced cellular motility (8).…”
mentioning
confidence: 99%